2026. In Silico Investigation of DLBS3233 Bioactives Targeting Inflammatory, Metabolic, and Cholesterol Transport Pathways in Gallstone (Cholelithiasis) Pathogenesis. Nutrición Clínica y Dietética Hospitalaria. 46, 1 (Feb. 2026). DOI:https://doi.org/10.12873/461baulia.